Results 131 to 140 of about 2,106 (155)

Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

American Journal of Health-System Pharmacy, 2005
Jon D Herrington, Ralph V Boccia
exaly  

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients

Kidney International, 2002
Yves Vanrenterghem, Peter Barany, Peter G Kerr   +2 more
exaly  

Darbepoetin-alfa/hydroxycarbamide

Reactions Weekly, 2022
openaire   +1 more source

Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease

Pediatric Nephrology, 2002
Bradley A Warady, Kathy Jabs, Warady Bradley A   +2 more
exaly  

Darbepoetin alfa for the treatment of anemic patients with low- and intermediate-1-risk myelodysplastic syndromes

Annals of Oncology, 2005
R Stasi, E Abruzzese, G Lanzetta
exaly  

Darbepoetin Alfa

2021
openaire   +1 more source

An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis

Journal of Internal Medicine, 2006
N Varma
exaly  

Darbepoetin-alfa

Reactions Weekly, 2019
openaire   +1 more source

Darbepoetin-alfa/thalidomide

Reactions Weekly, 2023
openaire   +1 more source

What is the practical conversion dose when changing from epoetin alfa to darbepoetin outside of clinical trials?

Nephrology, 2004
Simon D Roger, Bruce A Cooper
exaly